It is quite obvious that Dr Lucire is scientifically and absolutely correct in her concern about genetic variation and drug response.

This 52 minute video dated February 2006, nearly 5 years ago, is called

"Opportunities For Pharmacogenomics and Personalized Medicine"

VIDEO: http://video.google.com/videoplay?docid=5976890974902036286#

.

Professor Russ B Altman is "director of the Center for Biomedical Computation at Stanford University and is director of the biomedical informatics training program. He is also the principal investigator of a project, PharmGKB, which is an online database of genetic and phenotype information from people who have participated in research studies at various medical centers participating in the PGRN.

ABSTRACT Pharmacogenomics is the study of how variation in human genes leads to variation in drug response. One of the major promises of the genome project was to improve medical outcomes for patients by using knowledge of their genetic background.

The PharmGKB (Pharmacogenomics & Pharmacogenetics Knowledge Base, http:// www.pharmgkb.org/) is an NIH-funded resource at Stanford University charged with supporting the research community in pharmacogenomics, by storing both genetic variation information and drug-response information, building tools to help scientists visualize and analyze the data, curating the pharmacogenomics scientific literature (both manually and through text processing algorithms), representing pathways of genes that work together to affect drug response, and providing expert annotation of current pharmacogenomic knowledge"

Dr. Magnus Ingelman-Sundberg at the April 10, 2009 Conference at University of California, San Diego, presents his recent paper on:

"Pharmacogenomic biomarkers for prediction of "severe adverse drug reactions"

16 mins VIDEO: http://www.scivee.tv/node/10761
.

Some of Professor Ingelman-Sundberg's publications, such as
"The human genome project and novel aspects of cytochrome P450 research
Magnus Ingelman Sundberg
Division of Molecular Toxicology, IMM, Karolinska Institutet, SE 171 77 Stockholm, Sweden
Toxicol Appl Pharmacol 207:52-6"

can be accessed at:
http://www.labome.org/expert/sweden/karolinska/ingelman-sundberg/magnus-ingelman-sundberg-384718.html

To quote Jonathan Emord in discussion of his book, “The Rise of Tyranny”:
In my book The Rise of Tyranny I explain that FDA has become a captive of the drug industry and that repeatedly its Commissioner approves drugs over the safety objections of FDA medical reviewers. Dr. David Graham, FDA’s Associate Director of the Office of Drug Safety, has severely criticized his own agency for repeatedly approving unsafe drugs. “FDA is inherently biased in favor of the pharmaceutical industry,” said Dr. Graham. “It views industry as its client whose interests it must represent and advance. It views its primary mission as approving as many drugs as it can, regardless of whether the drugs are safe or needed.” Indeed, FDA performs no drug safety testing of drugs but relies entirely on the drug sponsor’s own testing. If the drug sponsor, who has an obvious economic interest in either not revealing or downplaying risks, fails to bring all identified risks to the agency’s attention, the agency presumes those risks de minimis or non-existent. Perhaps as many as 15% to 20% of all drugs on the market today are ones that carry serious side effects, including heart attack, stroke, neurological disorders, kidney failure, liver failure, and death. http://www.newswithviews.com/Emord/jonathan169.htm

To quote Jonathan Emord from his latest book, “Global Censorship of Health Information”, otherwise known as, “The Politics of Controlling Therapeutic Information to Protect State-Sponsored Drug Monopolies”, from page 30, second paragraph,
“By forbidding all actual and potential competitors from the market, governments worldwide ensure that companies holding a government license or grant of approval to market a drug enjoy total exclusivity and can set literally any price the market will bear for the approved drug. When a drug is approved for a disease, therefore, it is possible for a drug company to price each unit at hundreds or thousands or even tens of thousands of times the cost of making it, at the price calculated to achieve the highest profit.”
When those responsible for separation of powers in the legislature, the executive and the judiciary merge under an all powerful bureaucratic oligarchy having devolved into utter corruption, does this mean they just don’t give a damn about patient safety? Is this why Pharmacogenetics and Cytochrome P-450 Testing is facing such unwarranted delay in wholesale introduction into Australian Health Services?
Is this profit motive the reason why 25% of US children are now on chronic prescription medications? http://www.naturalnews.com/030879_children_drugs.html Is it true all they care about is these massive profits and to hell with patient safety? Is it just deceit and greed?
Jonathan Emord: http://www.google.com.au/#hl=en&source=hp&biw=941&bih=770&q=jonathan+emord&aq=f&aqi=g1g-v9&aql=&oq=&gs_rfai=&fp=19436dfea8718869

It is becoming clearer that the abhorent abuse of these medications is worth an examination. But then again, who will examine them? Its like arguing to Ceasar about Ceasar. But then again, what if Ceasar is being lied to as well? What if the Taxpayer is funding a massive fraud?

I recenetly read an article based upon the Qui Tam Legislation in the USA. Please read this, as it provides the people being (maimed and possibly murdered) with a remedy.

It is time that Politicians began to take notice of the people.
I have added the link below.

Please let me know if you think this would be a good idea in Australia?

http://www.cla.asn.au/0805/index.php/articles/2010/qui-tam-do-we-need#more9747

Its sad to see that we live under a cleverly designed semblance of moral and ethical reality. Its Kindergarten on a global scale.

May the new year bring some normalacy to this designed insanity.

Further to my Previous post I need to add this.

Dr. Lucire’s submission to the current Senate Suicide Inquiry is referenced to leading journals and the NSW Department of Health.

http://www.aph.gov.au/Senate/committee/clac_ctte/suicide/submissions/sub243.pdf

43 homicides and nearly 1,000 suicides under mental health care in NSW since 1992.

Calculate Australian deaths by looking at NSW, which has one third of the population. That is not to say the drugs are no good, they are being used badly and for conditions they cannot relieve.

Mental Health care is where these new drugs are being given in various combinations with disastrous outcomes.

If you want to know why someone died under NSW Mental Health care, it costs $30,000 to get a coroner to look.

And if the coroner finds negligence, he bills you, not the Department of Health. You still have to sue to get it back, and that costs thousands more dollars.

Deaths from adverse drug reactions/interactions (ADRs) are among the four big killers: cancer, heart attacks, and strokes. They need the same level of research funding as the big ones as they fill hospital beds and generate similar costs.

ADRs are being swept under the carpet.

http://psychrights.org/states/Alaska/CaseOne/30-Day/ExhibitD-Olanzapine.ht